Published in Neurology on January 08, 2002
Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology (2008) 3.04
Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress. J Neurosci Res (2004) 1.32
Clinical trials for cytoprotection in stroke. NeuroRx (2004) 1.08
The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease. Int J Mol Sci (2013) 1.07
Aquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rodents. PLoS One (2013) 1.04
Beyond free radical scavenging: Beneficial effects of edaravone (Radicut) in various diseases (Review). Exp Ther Med (2011) 0.93
VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid. Bioorg Med Chem (2013) 0.88
Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction. Exp Ther Med (2011) 0.81
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Interobserver agreement for the assessment of handicap in stroke patients. Stroke (1988) 20.14
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
[TIA... an aspirin?]. Ned Tijdschr Geneeskd (1995) 5.21
Oral contraceptives and the risk of myocardial infarction. N Engl J Med (2001) 5.18
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry (2001) 4.51
Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke (1997) 4.13
Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke (1998) 4.12
Handedness and hemispheric language dominance in healthy humans. Brain (2000) 3.80
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke (1996) 3.67
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology (2002) 3.57
Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke (2003) 3.56
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet (2000) 3.33
[Fever, large eyes and confusion; the anticholinergic syndrome]. Ned Tijdschr Geneeskd (2002) 3.30
Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry (2007) 3.17
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? Int J Geriatr Psychiatry (2001) 3.09
[Those who cannot remember the past are condemned to repeat it]. Ned Tijdschr Geneeskd (2006) 2.98
Intracerebral hematomas during anticoagulant treatment. Stroke (1990) 2.97
Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke (2005) 2.69
The outer arterial wall layers are primarily affected in spontaneous cervical artery dissection. Neurology (2011) 2.64
Restriction in complex activities of daily living in MCI: impact on outcome. Neurology (2006) 2.64
How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol (2009) 2.49
Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke (1999) 2.49
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ (2001) 2.43
Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke (1998) 2.40
Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systematic review. Neurology (1998) 2.39
Spinal dural arteriovenous fistulas: a congestive myelopathy that initially mimics a peripheral nerve disorder. Brain (2006) 2.35
Association of intraoperative transcranial doppler monitoring variables with stroke from carotid endarterectomy. Stroke (2000) 2.33
Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry (1999) 2.33
Hypertension and cerebral white matter lesions in a prospective cohort study. Brain (2002) 2.31
Circle of Willis: morphologic variation on three-dimensional time-of-flight MR angiograms. Radiology (1998) 2.30
Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet (1991) 2.30
The diagnosis of subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 2.29
Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet (2001) 2.29
Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology (2010) 2.21
Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke (1991) 2.19
Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology (1985) 2.18
Grading white matter lesions on CT and MRI: a simple scale. J Neurol Neurosurg Psychiatry (1990) 2.15
Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke (1994) 2.14
Thunderclap headache as first symptom of cerebral venous sinus thrombosis. CVST Study Group. Lancet (1996) 2.14
Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation (1995) 2.13
Carotid endarterectomy with transcranial Doppler and electroencephalographic monitoring. A prospective study in 130 operations. Stroke (1993) 2.13
Marchiafava-Bignami disease: diffusion-weighted MRI in corpus callosum and cortical lesions. Neurology (2005) 2.09
Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (2007) 2.08
The time course of aneurysmal haemorrhage on computed tomograms. Neuroradiology (1982) 2.06
Ticlopidine, trials, and torture. Stroke (1994) 2.04
[Effectiveness of endarterectomy for symptomatic stenosis of the internal carotid artery; more risk factors important than only the severity of the stenosis]. Ned Tijdschr Geneeskd (2007) 2.04
Hyperinsulinism and cerebral microangiopathy. Stroke (1996) 2.03
Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone? J Neurol Neurosurg Psychiatry (1999) 2.03
[There is no such thing as the CVA]. Ned Tijdschr Geneeskd (1991) 2.03
[Functional imaging of the brain in the investigation of chronic unexplained pain]. Ned Tijdschr Geneeskd (2007) 2.02
Degree of language lateralization determines susceptibility to unilateral brain lesions. Nat Neurosci (2002) 1.98
Xanthochromia after subarachnoid haemorrhage needs no revisitation. J Neurol Neurosurg Psychiatry (1989) 1.95
[Thrombolytic therapy of brain infarct: the end of beginning]. Ned Tijdschr Geneeskd (2000) 1.94
PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome. Lancet (1993) 1.92
Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. Stroke (1997) 1.92
[Possible treatments for patients with symptomatic carotid artery stenosis]. Ned Tijdschr Geneeskd (2005) 1.92
The clinical course of perimesencephalic nonaneurysmal subarachnoid hemorrhage. Ann Neurol (1991) 1.89
Warning headache in aneurysmal subarachnoid hemorrhage. A case-control study. Arch Neurol (1988) 1.89
Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg (1985) 1.87
Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry (1996) 1.87
Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain (2005) 1.85
Ischemic stroke in young adults. Experience in 329 patients enrolled in the Iowa Registry of stroke in young adults. Arch Neurol (1995) 1.83
Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke (1990) 1.83
Mortality and morbidity of surgery for unruptured intracranial aneurysms: a meta-analysis. Stroke (1998) 1.82
Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology (2000) 1.80
A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia (2009) 1.76
Mild mechanical traumas are possible risk factors for cervical artery dissection. Cerebrovasc Dis (2006) 1.75
The Corsi Block-Tapping Task: standardization and normative data. Appl Neuropsychol (2000) 1.74
Long-term follow-up of 71 patients with thunderclap headache mimicking subarachnoid haemorrhage. Lancet (1988) 1.73
Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage. J Neurosurg (2001) 1.73
Spinal infarction. A follow-up study. Stroke (1993) 1.72
[On the way to our 200th anniversary]. Ned Tijdschr Geneeskd (2007) 1.72
Apnoea testing to confirm brain death in clinical practice. J Neurol Neurosurg Psychiatry (1986) 1.72
Lesch-Nyhan disease and the basal ganglia. Brain Res Brain Res Rev (2000) 1.71
[Diagnostic image (156). A man with a hematoma behind the ear. Mastoid bone fracture]. Ned Tijdschr Geneeskd (2003) 1.69
Common carotid intima-media thickness and arterial stiffness: indicators of cardiovascular risk in high-risk patients. The SMART Study (Second Manifestations of ARTerial disease). Circulation (1999) 1.69
[Creative mathematics with clopidogrel; exaggeration of the preventive effect by manufacturer]. Ned Tijdschr Geneeskd (1999) 1.68